GlassScriptPhysician profile
Thomas Daniel Griffin
NPI 1336402775
$3,642.88
in general payments reported to CMS, 2019-2025
21 companies · $695 in 2025
The $695 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,170 · 2020: $340 · 2021: $64.44 · 2022: $434 · 2023: $387 · 2024: $553 · 2025: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,573.10 | 2019-2025 | |
| Genzyme Corporation | $467.87 | 2019-2025 | |
| Janssen Biotech, INC. | $310.39 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $191.81 | 2019-2024 | Olumiant, Taltz, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $183.94 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $141.03 | 2019-2025 | |
| Galderma Laboratories, L.P. | $119.32 | 2019-2025 | Nemluvio, Dysport |
| Ucb, INC. | $87.11 | 2019-2025 | Bimzelx |
| Paladin Technology Solutions | $82.01 | 2023-2024 | |
| Leo Pharma INC. | $78.68 | 2022-2024 | Adbry |
| Genentech USA, INC. | $70.51 | 2019-2020 | |
| Springworks Therapeutics, INC. | $64.77 | 2025 | Gomekli |
| Sun Pharmaceutical Industries INC. | $57.79 | 2022-2025 | |
| Amgen INC. | $51.31 | 2022-2025 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $39.28 | 2022-2024 | Sotyktu |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $28.36 | 2025 | Sofdra |
| Celgene Corporation | $24.23 | 2019 | |
| Dermira, INC. | $20.60 | 2020 | |
| Almirall LLC | $19.82 | 2025 | Klisyri |
| Helsinn Therapeutics (U.S.), INC. | $15.56 | 2019 | |
| Journey Medical Corporation | $15.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.